BAC
Bank of America Corporation
BAC has a slight edge over HDB overall, supported by stronger modeled upside and lower modeled downside.
HDB
HDFC Bank Limited
HDB trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
HDB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
HDB's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like HDB.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
HDB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 16x | $25.71 | — |
| Cheap | 19x | $30.82 | +20% |
| Fair | 23x | $37.39 | +45% |
| Expensive | 29x | $47.45 | +85% |
Historical ranges are pointers, not guarantees.
HDB has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over HDB on the outlook, with more favorable profitability expectations.
HDB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for HDB, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over HDB on earnings, with stronger typical year-over-year growth.
HDB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.65 | +13% |
| Q1 2026 | $1.59 | +8.2% |
| Q4 2025 | $1.56 | +7.6% |
| Q3 2025 | $1.51 | +4.9% |
| Q2 2025 | $1.46 | +8.1% |
| Q1 2025 | $1.47 | +8.9% |
| Q4 2024 | $1.45 | +8.2% |
| Q3 2024 | $1.44 | +7.5% |
HDB's earnings per share have climbed steadily: $1.65 over the past year, up 13% from the year before, and higher year over year for eight quarters in a row.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over HDB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over HDB on profitability, with a higher operating margin.
HDB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $14.3B | +0.8% |
| Q1 2026 | $12.7B | +72% |
| Q4 2025 | $13.7B | +14% |
| Q3 2025 | $12.9B | +33% |
| Q2 2025 | $14.2B | +14% |
| Q1 2025 | $7.3B | +0.5% |
| Q4 2024 | $12B | -2.5% |
| Q3 2024 | $9.6B | -16% |
HDB's revenue has grown year over year for six quarters in a row: $14.3B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 20% | +4.8 points |
| Q1 2026 | 24% | +1.2 points |
| Q4 2025 | 21% | -0.1 points |
| Q3 2025 | 22% | -0.5 points |
| Q2 2025 | 16% | -3.8 points |
| Q1 2025 | 22% | +5.3 points |
| Q4 2024 | 21% | +2.9 points |
| Q3 2024 | 23% | +3.5 points |
HDB's operating margin was 20% last quarter, up 4.8 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over HDB on cash flow, with more consistent year-over-year improvement.
HDB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $18.4B | +$18.4B |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
HDB's free cash flow was $18.4B over the past year, against $0 the year before. Free cash flow isn't a meaningful measure for financial services companies like HDB.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over HDB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
HDB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -2.6M shares |
| 1 year | +0.2% | +12.4M shares |
| 3 years | +37% | +1.4B shares |
| 5 years | +39% | +1.5B shares |
| Available history | +39% | +1.5B shares |
HDB has 5.1B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
HDB hasn't bought back shares in the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
HDB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.0x | Elevated |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 4.8x | High |
| Q2 2025 | 4.8x | High |
| Q1 2025 | 5.1x | High |
| Q4 2024 | 5.3x | High |
| Q3 2024 | 7.1x | High |
HDB has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
HDB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.2 | Neutral |
| Stochastic | 68.2 | Neutral |
HDB's weekly RSI is 55 (neutral) and its Stochastic is 68 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over HDB on valuation relative to its sector.
HDB PE vs Financial Services Sector
| Metric | HDB | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 20% above |
| PE % | 5 | 63 | 58 pts below |
HDB is trading at 16x earnings, a 20% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
HDB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.3 | 10% above |
| 20 week MA | $23.8 | 8.1% above |
| 50 week MA | $27.0 | 4.9% below |
| 100 week MA | $30.9 | 17% below |
| 200 week MA | $31.1 | 17% below |
HDB has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over HDB on returns for 2026, with the stronger performance.
HDB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.6 | $34.8 | +10% |
| 2021 | $34.8 | $31.6 | -9.1% |
| 2022 | $31.6 | $33.4 | +5.7% |
| 2023 | $33.4 | $33.6 | +0.4% |
| 2024 | $33.6 | $32.3 | -3.8% |
| 2025 | $32.3 | $36.5 | +13% |
| 2026 YTD | $36.5 | $25.7 | -29% |
HDB has finished higher in four of the last six years. It's down 29% so far in 2026.